$MRK Recent News Apple green ahead of earnings;
Post# of 89380
Posted On: 01/31/2014 1:55:22 PM
$MRK Recent News
Apple green ahead of earnings; Caterpillar tops gainers 3:42 p.m. Jan. 27, 2014 - Saumya Vaishampayan
Technical damage inflicted, S&P’s trend turns lower 11:49 a.m. Jan. 27, 2014 - Michael Ashbaugh
Merck hits a new high as analyst sees opening for new cancer drug 11:16 a.m. Jan. 27, 2014 - blogs.marketwatch.com
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 4:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Beam up on Suntory deal; Elliott report lifts Juniper 4:17 p.m. Jan. 13, 2014 - Saumya Vaishampayan
Merck shares hit 52-week high on drug hopes, plans for cutbacks 12:31 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Merck initiates melanoma filing with FDA 11:45 a.m. Jan. 13, 2014 - Tess Stynes
Merck shares rise 3%, best on Dow average 9:41 a.m. Jan. 13, 2014 - Laura Mandaro
Statin usefulness questioned, but patent expirations may ease pain 1:02 p.m. Jan. 8, 2014 - blogs.marketwatch.com
Cholesterol drugs: Do you need them, or not? 5:00 a.m. Jan. 8, 2014 - Elizabeth O'Brien
Buying the 2014 recovery 12:01 a.m. Jan. 7, 2014 - Jim Lowell
Merck, Twitter, Apple are stocks to watch 4:34 p.m. Dec. 29, 2013 - Wallace Witkowski
Merck to revamp its R&D practices: WSJ 4:49 p.m. Dec. 27, 2013 - Wallace Witkowski
Merck to radically reshape R&D unit: WSJ 4:40 p.m. Dec. 27, 2013 - Wallace Witkowski
Not all pharmaceuticals are created equal 12:39 p.m. Dec. 26, 2013 - The Trading Deck
EU approves Merck's Erbitux for cancer treatment 4:52 a.m. Dec. 23, 2013 - MarketWatch.com
Biotechs continue to pay off 10:27 a.m. Dec. 20, 2013 - The Trading Deck
Safe and steady ETFs for the new year 12:03 p.m. Dec. 9, 2013 - Jim Lowell
Merck, McDonald's are top decliners in Dow index 4:05 p.m. Dec. 4, 2013 - Polya Lesova
Cuts, stock buyback, acquisition combine to boost Forest shares 11:09 a.m. Dec. 2, 2013 - blogs.marketwatch.com
6 Reasons Why Bristol-Myers Is A Good Immuno-Oncology Investment For 2014 7:52 a.m. Today - Seeking Alpha
Merck Ends Use of Chimpanzees in Research 6:15 p.m. Jan. 30, 2014 - WSJ.com
AstraZeneca Ends Tropical-Disease Research 7:58 a.m. Jan. 30, 2014 - WSJ.com
5 Stocks Pulling The Drugs Industry Downward 12:02 p.m. Jan. 29, 2014 - TheStreet.com
An Option On Adoption Of A New Multiple Sclerosis Treatment 8:51 a.m. Jan. 29, 2014 - Seeking Alpha
Bayer's Aleve May Have Lower Cardiac Risk Than Rival Painkillers 7:20 p.m. Jan. 28, 2014 - WSJ.com
Stability With The 'Everyday American' Portfolio 12:04 p.m. Jan. 28, 2014 - Seeking Alpha
Questcor 57% January Upside Eclipsed Healthcare Dogs 9:36 a.m. Jan. 28, 2014 - Seeking Alpha
Pfizer: Bad Quarter, Good Year, Better Outlook 9:35 a.m. Jan. 28, 2014 - Wall St. Cheat Sheet
Will Recent Headlines Hurt Pfizer Stock? 8:29 a.m. Jan. 28, 2014 - Wall St. Cheat Sheet
'Fast Money' Recap: Getting to the Core of Apple 5:00 a.m. Jan. 28, 2014 - TheStreet.com
The Acquisition Of Mills Pharmaceuticals Put Another Arrow In The Quiver Of Galena 6:07 p.m. Jan. 27, 2014 - Seeking Alpha
Merck & Co Inc (MRK): Today's Featured Drugs Winner 5:00 p.m. Jan. 27, 2014 - TheStreet.com
Merck’s New Cancer Drug Boosts Its Rating 4:38 p.m. Jan. 27, 2014 - Wall St. Cheat Sheet
The 5 Stocks That Dominated the Market on Monday 3:35 p.m. Jan. 27, 2014 - 247WallSt.com
Update on Endocyte Candidates - Analyst Blog 1:30 p.m. Jan. 27, 2014 - Zacks.com
Merck +2.8% as Morgan Stanley sees opening for new cancer drug 12:32 p.m. Jan. 27, 2014 - Seeking Alpha
Interesting January 2016 Stock Options For MRK 12:01 p.m. Jan. 27, 2014 - TheStreet.com
Obamacare Boosts Health Funds 11:26 a.m. Jan. 27, 2014 - TheStreet.com
Dow Today: Merck (MRK) Higher 11:00 a.m. Jan. 27, 2014 - TheStreet.com
TechConnect, National Innovation, and SBIR/STTR Summit Announce Top Corporate Partners and Innovation Submission Deadline 10:30 a.m. Jan. 30, 2014 - PR Newswire - PRF
Critical Alerts For Advanced Micro Devices, Merck, Urban Outfitters, Peabody Energy, and TakeTwo Interactive Released By InvestorsObserver 9:31 a.m. Jan. 30, 2014 - PR Newswire - PRF
FDA Advisory Committee recommends approval of ragweed sublingual allergy immunotherapy tablet 3:02 p.m. Jan. 28, 2014 - GlobeNewswire
RXI Pharmaceuticals Could Benefit from Biotech Industry Dynamics 10:06 a.m. Jan. 24, 2014 - ACCESSWIRE
ALK announces posting of briefing documents for FDA Advisory Committee meeting on the ragweed sublingual tablet 8:05 a.m. Jan. 24, 2014 - GlobeNewswire
Formex CSO Blair West to Speak at 3rd Drug Formulation & Bioavailability Conference 10:00 a.m. Jan. 23, 2014 - PR Newswire - PRF
Pharmerging Markets 2012-2016 11:12 a.m. Jan. 22, 2014 - PR Newswire - PRF
John Daly, Previous Merck Exec., Offers Consulting Tips 6:35 p.m. Jan. 17, 2014 - Marketwire
Sanford Heisler Adds Four New Class Representatives To $250M Gender Discrimination Class Action Suit Against Pharma Giant Merck 10:03 a.m. Jan. 17, 2014 - PR Newswire - PRF
Trimel Announces Appointment of Tom Rossi to Its Board of Directors 5:08 p.m. Jan. 16, 2014 - Marketwire
Merck Statement on FDA Advisory Committee for Vorapaxar, Merck’s Investigational Antiplatelet Medicine 6:59 p.m. Jan. 15, 2014 - BusinessWire - BZX
Merck Provides Update on Accelerated Strategic Actions for Growth at 32nd Annual J.P. Morgan Healthcare Conference 8:35 a.m. Jan. 13, 2014 - BusinessWire - BZX
Merck Initiates Rolling Submission of U.S. Biologics License Application for MK-3475, an Investigational Anti-PD-1 Immunotherapy, in Patients with Advanced Melanoma 8:30 a.m. Jan. 13, 2014 - BusinessWire - BZX
Alnylam Acquires Investigational RNAi Therapeutic Assets from Merck 9:00 p.m. Jan. 12, 2014 - BusinessWire - BZX
Biotech Investing Strategies in 2014 Is Key Topic Bringing Investors to San Francisco for Biotech Showcase(TM) 2014 Next Week, January 13 10:59 a.m. Jan. 9, 2014 - BusinessWire
Dako to collaborate with Merck on development of companion diagnostics for cancer treatment 9:16 a.m. Jan. 9, 2014 - GlobeNewswire
Dako to collaborate with Merck on development of companion diagnostics for cancer treatment 9:00 a.m. Jan. 9, 2014 - Thomson Reuters ONE
Merck Receives FDA Approval for ISENTRESS(R) (raltegravir) for Pediatric Oral Suspension 8:29 a.m. Jan. 8, 2014 - BusinessWire
Health Care Sector Under the Lens: Pfizer, Merck & Co., AbbVie and Zogenix 8:00 a.m. Jan. 8, 2014 - PR Newswire
Presentation Schedules, Stock Movements, Agreements, and New Appointments - Research Report on Celgene, Merck, Bristol-Myers, Valeant, and Mylan 8:00 a.m. Jan. 7, 2014 - PR Newswire
Apple green ahead of earnings; Caterpillar tops gainers 3:42 p.m. Jan. 27, 2014 - Saumya Vaishampayan
Technical damage inflicted, S&P’s trend turns lower 11:49 a.m. Jan. 27, 2014 - Michael Ashbaugh
Merck hits a new high as analyst sees opening for new cancer drug 11:16 a.m. Jan. 27, 2014 - blogs.marketwatch.com
Dow industrials suffer worst drop since Sept. 20: Stock market live blog recap 4:41 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Beam up on Suntory deal; Elliott report lifts Juniper 4:17 p.m. Jan. 13, 2014 - Saumya Vaishampayan
Merck shares hit 52-week high on drug hopes, plans for cutbacks 12:31 p.m. Jan. 13, 2014 - blogs.marketwatch.com
Merck initiates melanoma filing with FDA 11:45 a.m. Jan. 13, 2014 - Tess Stynes
Merck shares rise 3%, best on Dow average 9:41 a.m. Jan. 13, 2014 - Laura Mandaro
Statin usefulness questioned, but patent expirations may ease pain 1:02 p.m. Jan. 8, 2014 - blogs.marketwatch.com
Cholesterol drugs: Do you need them, or not? 5:00 a.m. Jan. 8, 2014 - Elizabeth O'Brien
Buying the 2014 recovery 12:01 a.m. Jan. 7, 2014 - Jim Lowell
Merck, Twitter, Apple are stocks to watch 4:34 p.m. Dec. 29, 2013 - Wallace Witkowski
Merck to revamp its R&D practices: WSJ 4:49 p.m. Dec. 27, 2013 - Wallace Witkowski
Merck to radically reshape R&D unit: WSJ 4:40 p.m. Dec. 27, 2013 - Wallace Witkowski
Not all pharmaceuticals are created equal 12:39 p.m. Dec. 26, 2013 - The Trading Deck
EU approves Merck's Erbitux for cancer treatment 4:52 a.m. Dec. 23, 2013 - MarketWatch.com
Biotechs continue to pay off 10:27 a.m. Dec. 20, 2013 - The Trading Deck
Safe and steady ETFs for the new year 12:03 p.m. Dec. 9, 2013 - Jim Lowell
Merck, McDonald's are top decliners in Dow index 4:05 p.m. Dec. 4, 2013 - Polya Lesova
Cuts, stock buyback, acquisition combine to boost Forest shares 11:09 a.m. Dec. 2, 2013 - blogs.marketwatch.com
6 Reasons Why Bristol-Myers Is A Good Immuno-Oncology Investment For 2014 7:52 a.m. Today - Seeking Alpha
Merck Ends Use of Chimpanzees in Research 6:15 p.m. Jan. 30, 2014 - WSJ.com
AstraZeneca Ends Tropical-Disease Research 7:58 a.m. Jan. 30, 2014 - WSJ.com
5 Stocks Pulling The Drugs Industry Downward 12:02 p.m. Jan. 29, 2014 - TheStreet.com
An Option On Adoption Of A New Multiple Sclerosis Treatment 8:51 a.m. Jan. 29, 2014 - Seeking Alpha
Bayer's Aleve May Have Lower Cardiac Risk Than Rival Painkillers 7:20 p.m. Jan. 28, 2014 - WSJ.com
Stability With The 'Everyday American' Portfolio 12:04 p.m. Jan. 28, 2014 - Seeking Alpha
Questcor 57% January Upside Eclipsed Healthcare Dogs 9:36 a.m. Jan. 28, 2014 - Seeking Alpha
Pfizer: Bad Quarter, Good Year, Better Outlook 9:35 a.m. Jan. 28, 2014 - Wall St. Cheat Sheet
Will Recent Headlines Hurt Pfizer Stock? 8:29 a.m. Jan. 28, 2014 - Wall St. Cheat Sheet
'Fast Money' Recap: Getting to the Core of Apple 5:00 a.m. Jan. 28, 2014 - TheStreet.com
The Acquisition Of Mills Pharmaceuticals Put Another Arrow In The Quiver Of Galena 6:07 p.m. Jan. 27, 2014 - Seeking Alpha
Merck & Co Inc (MRK): Today's Featured Drugs Winner 5:00 p.m. Jan. 27, 2014 - TheStreet.com
Merck’s New Cancer Drug Boosts Its Rating 4:38 p.m. Jan. 27, 2014 - Wall St. Cheat Sheet
The 5 Stocks That Dominated the Market on Monday 3:35 p.m. Jan. 27, 2014 - 247WallSt.com
Update on Endocyte Candidates - Analyst Blog 1:30 p.m. Jan. 27, 2014 - Zacks.com
Merck +2.8% as Morgan Stanley sees opening for new cancer drug 12:32 p.m. Jan. 27, 2014 - Seeking Alpha
Interesting January 2016 Stock Options For MRK 12:01 p.m. Jan. 27, 2014 - TheStreet.com
Obamacare Boosts Health Funds 11:26 a.m. Jan. 27, 2014 - TheStreet.com
Dow Today: Merck (MRK) Higher 11:00 a.m. Jan. 27, 2014 - TheStreet.com
TechConnect, National Innovation, and SBIR/STTR Summit Announce Top Corporate Partners and Innovation Submission Deadline 10:30 a.m. Jan. 30, 2014 - PR Newswire - PRF
Critical Alerts For Advanced Micro Devices, Merck, Urban Outfitters, Peabody Energy, and TakeTwo Interactive Released By InvestorsObserver 9:31 a.m. Jan. 30, 2014 - PR Newswire - PRF
FDA Advisory Committee recommends approval of ragweed sublingual allergy immunotherapy tablet 3:02 p.m. Jan. 28, 2014 - GlobeNewswire
RXI Pharmaceuticals Could Benefit from Biotech Industry Dynamics 10:06 a.m. Jan. 24, 2014 - ACCESSWIRE
ALK announces posting of briefing documents for FDA Advisory Committee meeting on the ragweed sublingual tablet 8:05 a.m. Jan. 24, 2014 - GlobeNewswire
Formex CSO Blair West to Speak at 3rd Drug Formulation & Bioavailability Conference 10:00 a.m. Jan. 23, 2014 - PR Newswire - PRF
Pharmerging Markets 2012-2016 11:12 a.m. Jan. 22, 2014 - PR Newswire - PRF
John Daly, Previous Merck Exec., Offers Consulting Tips 6:35 p.m. Jan. 17, 2014 - Marketwire
Sanford Heisler Adds Four New Class Representatives To $250M Gender Discrimination Class Action Suit Against Pharma Giant Merck 10:03 a.m. Jan. 17, 2014 - PR Newswire - PRF
Trimel Announces Appointment of Tom Rossi to Its Board of Directors 5:08 p.m. Jan. 16, 2014 - Marketwire
Merck Statement on FDA Advisory Committee for Vorapaxar, Merck’s Investigational Antiplatelet Medicine 6:59 p.m. Jan. 15, 2014 - BusinessWire - BZX
Merck Provides Update on Accelerated Strategic Actions for Growth at 32nd Annual J.P. Morgan Healthcare Conference 8:35 a.m. Jan. 13, 2014 - BusinessWire - BZX
Merck Initiates Rolling Submission of U.S. Biologics License Application for MK-3475, an Investigational Anti-PD-1 Immunotherapy, in Patients with Advanced Melanoma 8:30 a.m. Jan. 13, 2014 - BusinessWire - BZX
Alnylam Acquires Investigational RNAi Therapeutic Assets from Merck 9:00 p.m. Jan. 12, 2014 - BusinessWire - BZX
Biotech Investing Strategies in 2014 Is Key Topic Bringing Investors to San Francisco for Biotech Showcase(TM) 2014 Next Week, January 13 10:59 a.m. Jan. 9, 2014 - BusinessWire
Dako to collaborate with Merck on development of companion diagnostics for cancer treatment 9:16 a.m. Jan. 9, 2014 - GlobeNewswire
Dako to collaborate with Merck on development of companion diagnostics for cancer treatment 9:00 a.m. Jan. 9, 2014 - Thomson Reuters ONE
Merck Receives FDA Approval for ISENTRESS(R) (raltegravir) for Pediatric Oral Suspension 8:29 a.m. Jan. 8, 2014 - BusinessWire
Health Care Sector Under the Lens: Pfizer, Merck & Co., AbbVie and Zogenix 8:00 a.m. Jan. 8, 2014 - PR Newswire
Presentation Schedules, Stock Movements, Agreements, and New Appointments - Research Report on Celgene, Merck, Bristol-Myers, Valeant, and Mylan 8:00 a.m. Jan. 7, 2014 - PR Newswire
(0)
(0)